Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002899250 | SCV003243821 | pathogenic | not provided | 2022-10-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with HPS3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg30Leufs*42) in the HPS3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS3 are known to be pathogenic (PMID: 11590544). |
Baylor Genetics | RCV004571790 | SCV005059708 | likely pathogenic | Hermansky-Pudlak syndrome 3 | 2024-03-24 | criteria provided, single submitter | clinical testing |